We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > coronavirus vaccine

News List

Rokote Laboratories selects Exothera for GMP manufacturing of its second-generation coronavirus vaccine FINCoVac 2.0. PharmaSources.com
April 07, 2022
Rokote Laboratories Finland Ltd., a vaccine development company focusing on a second-generation COVID-19 vaccine, and Exothera S.A. will collaborate to bring the intranasal coronavirus vaccine FINCoVac 2.0 to clinical Phase I/II trials.
UK to invest up to 93 million pounds in new coronavirus vaccine centre expresspharma
May 19, 2020
The funding will ensure the new centre opens in Summer 2021, a year ahead of schedule, the department said.
Evolving World of Pharma: Efforts for a coronavirus vaccine Sarah Harding
February 13, 2020
There is an immediate need for medicines that can help treat the acute respiratory disease, as well as the development of an effective vaccine.